𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A comparison of the effect of salmeterol and salbutamol in normal subjects.

✍ Scribed by J Spring; J Clague; PW Ind

Book ID
117945316
Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
561 KB
Volume
33
Category
Article
ISSN
0306-5251

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The effect of salbutamol on mood in norm
The effect of salbutamol on mood in normal subjects
✍ Dr David B. Menkes; J. Paul Fawcett; Megan R. Nunn; David Boothman-Burrell πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 353 KB πŸ‘ 1 views

## Abstract The beta‐2‐adrenoceptor agonist salbutamol, widely used in the treatment of asthma, is thought to have antidepressant activity and possibly an abuse liability. In order to examine the mood‐altering potential of this drug, a placebocontrolled, double‐blind crossover trial was conducted i

A comparison of the speeds of action of
A comparison of the speeds of action of salmeterol and salbutamol in reversing methacholine-induced bronchoconstriction
✍ J.R. Beach; C.L. Young; S.C. Stenton; A.J. Avery; E.H. Walters; D.J. Hendrick πŸ“‚ Article πŸ“… 1992 πŸ› Elsevier 🌐 English βš– 252 KB

We compared the speed of action of the long acting beta-agonist salmeterol with that of salbutamol in order to assess whether reported in vitro differences are likely to have clinical significance. We used methacholine tests to produce a standardized level of bronchoconstriction and then observed th

A comparison of the bronchodilating effe
A comparison of the bronchodilating effects of salmeterol, salbutamol and Ipratropium bromide in patients with chronic obstructive pulmonary disease
✍ M.G. Matera; M. Cazzola; A. Vinciguerra; F. Di Perna; F. Calderaro; M. Caputi; F πŸ“‚ Article πŸ“… 1995 πŸ› Elsevier 🌐 English βš– 587 KB

Bronchodilator efficacy of salbutamol (200 pg), salmeterol (50 pg) and ipratropium bromide (40 pg) aerosols has been compared in 16 patients with stable chronic obstructive pulmonary disease (COPD) using a double-blind placebo controlled cross-over design. When absolute changes in FEV~ were used as